CRIS Current Research Information System

GELSOMINO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.236
EU - Europa 892
AS - Asia 768
AF - Africa 82
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 2.981
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.234
CN - Cina 345
IT - Italia 254
VN - Vietnam 185
SE - Svezia 173
GB - Regno Unito 150
SG - Singapore 136
DE - Germania 105
IE - Irlanda 53
IN - India 51
TG - Togo 43
FR - Francia 35
JO - Giordania 25
CH - Svizzera 23
BG - Bulgaria 21
RU - Federazione Russa 18
CI - Costa d'Avorio 14
FI - Finlandia 12
ZA - Sudafrica 12
EE - Estonia 11
NL - Olanda 11
BE - Belgio 10
NG - Nigeria 8
ID - Indonesia 7
UA - Ucraina 7
EG - Egitto 4
IL - Israele 4
IR - Iran 4
AT - Austria 3
JP - Giappone 3
HR - Croazia 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BR - Brasile 1
CA - Canada 1
ES - Italia 1
GR - Grecia 1
LB - Libano 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
PK - Pakistan 1
SA - Arabia Saudita 1
SC - Seychelles 1
UZ - Uzbekistan 1
Totale 2.981
Salva come PNG Salva come JPEG
Città #
Shanghai 165
Fairfield 142
Dong Ket 140
Southend 137
Ashburn 128
Singapore 122
Chandler 118
Woodbridge 82
Houston 77
Seattle 62
Princeton 53
Cambridge 51
Dublin 51
Bologna 50
Wilmington 50
Santa Clara 46
Lomé 43
Ann Arbor 42
Boardman 31
Beijing 29
Amman 25
Turin 22
Bern 21
Florence 20
Redmond 20
Nanjing 18
Sofia 18
San Diego 16
Abidjan 14
Jinan 14
Westminster 14
Shenyang 12
Milan 11
Berlin 10
Helsinki 10
Bremen 9
Brussels 9
Des Moines 9
Medford 9
Abeokuta 8
Bühl 7
Jakarta 7
Kerpen 7
Redwood City 7
Los Angeles 6
Padova 6
Saint Petersburg 6
Tianjin 6
Boydton 5
Dearborn 5
Giv‘atayim 4
Guangzhou 4
Haikou 4
Hebei 4
Hyderabad 4
Nanchang 4
Sansepolcro 4
Taiyuan 4
Arezzo 3
Changsha 3
Chicago 3
Clearwater 3
Foshan 3
Groningen 3
Haltern 3
Jiaxing 3
London 3
Moncalieri 3
Naaldwijk 3
New York 3
Norwalk 3
Paris 3
Rome 3
Vienna 3
Acerra 2
Aspremont 2
Bari 2
Casal di Principe 2
Cheyenne 2
Chieti 2
Hangzhou 2
Hefei 2
Ho Chi Minh City 2
Kerken 2
Kunming 2
Lappeenranta 2
Limerick 2
Ningbo 2
Olalla 2
Podenzano 2
Portici 2
Prescot 2
Pune 2
Romainville 2
San Floriano del Collio 2
Sassuolo 2
Shenzhen 2
Tehran 2
Tokyo 2
Venezia 2
Totale 2.102
Salva come PNG Salva come JPEG
Nome #
IFN-γ and CD38 in Hyperprogressive Cancer Development 308
A case of nivolumab-related cholangitis and literature review: how to look for the right tools for a correct diagnosis of this rare immune-related adverse event 157
Arterial Embolization During Programmed Death-1 Inhibitor Treatment: An Unexpected Finding 146
Nivolumab-induced cholangitic liver disease: A novel form of serious liver injury 137
Beyond EGFR, ALK and ROS1: Current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma 134
Immune-mediated cholangitis: is it always nivolumab’s fault? 127
Complete Recalcification Following Arterial Embolization of Massive Osteolytic Bone Metastasis From NSCLC 124
Pembrolizumab in the treatment of metastatic non-small cell lung cancer: A review of current evidence 123
Atezolizumab in a CoHort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal SubtypEs (CHANCE trial) 123
18F-FLT PET/CT in patients with advanced Non-Small Lung Cancer (NSCLC) treated with Nivolumab: preliminary results 122
Anti-programmed cell death-1 and anti-programmed cell death ligand-1 immune-related liver diseases: from clinical pivotal studies to real-life experience 122
Validation of the immunohistochemical expression of programmed death ligand 1 (PD-L1) on cytological smears in advanced non small cell lung cancer 117
Clinical and hematologic parameters address the outcomes of non-small-cell lung cancer patients treated with nivolumab 115
KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC 110
The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC 109
The mechanisms of PD-L1 regulation in non-small-cell lung cancer (NSCLC): Which are the involved players? 105
Next-generation technologies in predictive molecular pathology of lung cancers 103
Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance 95
New disappearance of complicated atheromatous plaques on rechallenge with PD-1/PD-L1 axis blockade in non-small cell lung cancer patient: follow up of an unexpected event 94
Overcoming Primary Resistance to PD-1 Inhibitor With Anti–PD-L1 Agent in Squamous-Cell NSCLC: Case Report 81
Evolution of cystic airspaces lung lesions on immune checkpoint inhibition in non-small cell lung cancer 81
The evolving landscape of immunotherapy in small-cell lung cancer: A focus on predictive biomarkers 78
Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study 78
null 75
Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL) 68
Psychiatric Adverse Reactions to Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer: Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System 62
Phase II study of capecitabine-based concomitant chemoradiation followed by durvalumab as a neoadjuvant strategy in locally advanced rectal cancer: the PANDORA trial 26
Programmed death-1 inhibition and atherosclerosis: Can nivolumab vanish complicated atheromatous plaques? 25
Plasma genotyping for EGFR T790M in non-small cell lung cancer: Ready for clinical practice? 25
Immune checkpoint inhibitors in lung tumors with rare histologies and other thoracic malignancies 14
Peripheral nervous system adverse events associated with immune checkpoint inhibitors 14
Totale 3.098
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.935
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.935
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020355 0 0 0 0 38 43 64 58 69 29 26 28
2020/2021578 40 23 3 4 84 29 40 56 47 32 27 193
2021/2022516 41 17 26 22 59 30 20 27 46 31 122 75
2022/2023678 49 110 52 71 34 47 26 44 126 17 64 38
2023/2024422 24 25 15 19 17 57 13 189 12 22 24 5
2024/2025384 60 123 75 49 77 0 0 0 0 0 0 0
Totale 3.098